• #36 - Stella K. Vnook, CEO at Likarda

  • Mar 20 2024
  • Duración: 19 m
  • Podcast

#36 - Stella K. Vnook, CEO at Likarda Por arte de portada

#36 - Stella K. Vnook, CEO at Likarda

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.

    What you'll get out of this episode:

    • Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.
    • Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.
    • The company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.
    • Likarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.
    • Funding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.


    To learn more about our guests and their companies:
    LinkedIn: https://www.linkedin.com/in/vnook/
    Company LinkedIn: https://www.linkedin.com/company/likarda-llc/
    Website: https://likarda.com/

    Our sponsor for this episode are:
    Sage Growth Partners https://sage-growth.com/

    BioBreakthroughs is part of the Slice of Healthcare podcast network:
    LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre #36 - Stella K. Vnook, CEO at Likarda

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles